Purinergic 2X7 receptor/NLRP3 pathway triggers neuronal apoptosis after ischemic stroke in the mouse
- 1 June 2017
- journal article
- Published by Elsevier BV in Experimental Neurology
- Vol. 292, 46-55
- https://doi.org/10.1016/j.expneurol.2017.03.002
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81571155, 81571210)
- Jiangsu Provincial Medical Youth Talent (QNRC2016788)
This publication has 33 references indexed in Scilit:
- A reassessment of P2X7 receptor inhibition as a neuroprotective strategy in rat models of contusion injuryExperimental Neurology, 2012
- Adverse Effects of Bone Marrow Stromal Cell Treatment of Stroke in Diabetic RatsStroke, 2011
- Niaspan enhances vascular remodeling after stroke in type 1 diabetic ratsExperimental Neurology, 2011
- The P2 Receptor Antagonist PPADS Supports Recovery from Experimental Stroke In VivoPLOS ONE, 2011
- A role for mitochondria in NLRP3 inflammasome activationNature, 2010
- Inhibition of TRPC6 degradation suppresses ischemic brain damage in ratsJCI Insight, 2010
- The InflammasomesCell, 2010
- NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?Nature Reviews Immunology, 2010
- Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injuryProceedings of the National Academy of Sciences, 2009
- Altered P2X7‐receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administrationThe FASEB Journal, 2009